U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

I was basically a year ahead of him when I saw the writing on the wall,” Lally told Page Six in an exclusive interview Thursday in Los Angeles.

Researchers successfully treated a dog's anxiety with low-dose LSD, without adverse effects, opening new doors for pet ...

They affect 80% of UK women under 50 – and are the hidden trigger behind everything from debilitating periods to fertility ...